152 related articles for article (PubMed ID: 8869182)
1. Comparative and experimental pathology of fibrosing colonopathy.
van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV
Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
[TBL] [Abstract][Full Text] [Related]
2. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer.
Prescott P; Bakowski MT
Pharmacoepidemiol Drug Saf; 1999 Oct; 8(6):377-84. PubMed ID: 15073899
[TBL] [Abstract][Full Text] [Related]
4. The aetiology of fibrosing colonopathy.
Dodge JA
Postgrad Med J; 1996 Mar; 72 Suppl 2():S52-5. PubMed ID: 8869183
[No Abstract] [Full Text] [Related]
5. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis.
Bakowski MT; Prescott P
Pharmacoepidemiol Drug Saf; 1997 Sep; 6(5):347-58. PubMed ID: 15073770
[TBL] [Abstract][Full Text] [Related]
6. First adult patient with fibrosing colonopathy.
Häusler M; Meilicke R; Biesterfeld S; Heimann G
Am J Gastroenterol; 1998 Jul; 93(7):1171-2. PubMed ID: 9672356
[TBL] [Abstract][Full Text] [Related]
7. Fibrosing colonopathy in children with cystic fibrosis.
Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179
[No Abstract] [Full Text] [Related]
8. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
[TBL] [Abstract][Full Text] [Related]
9. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis.
Croft NM; Marshall TG; Ferguson A
Postgrad Med J; 1996 Mar; 72 Suppl 2():S32-6. PubMed ID: 8869180
[TBL] [Abstract][Full Text] [Related]
10. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy.
Mack EH; Brett AS; Brown D
South Med J; 2004 Sep; 97(9):901-4. PubMed ID: 15455984
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
Waters BL
Pediatr Dev Pathol; 1998; 1(1):74-8. PubMed ID: 10463274
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
Littlewood JM; Wolfe SP; Conway SP
Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
[TBL] [Abstract][Full Text] [Related]
13. Fibrosing colonopathy revealing cystic fibrosis in a neonate before any pancreatic enzyme supplementation.
Serban DE; Florescu P; Miu N
J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):356-9. PubMed ID: 12352527
[TBL] [Abstract][Full Text] [Related]
14. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
Ramsden WH; Moya EF; Littlewood JM
Arch Dis Child; 1998 Oct; 79(4):339-43. PubMed ID: 9875045
[TBL] [Abstract][Full Text] [Related]
15. Fibrosing Colonopathy Presenting in a Patient with Cystinosis.
Fiore D; Sohini V; Mileti E; Fiore N
JPGN Rep; 2023 Aug; 4(3):e321. PubMed ID: 37600607
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
[TBL] [Abstract][Full Text] [Related]
19. Fibrosing colonopathy in cystic fibrosis.
Smyth RL
Arch Dis Child; 1996 May; 74(5):464-8. PubMed ID: 8669970
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic enzymes and fibrosing colonopathy.
van Velzen D
Lancet; 1999 Jul; 354(9174):250-1. PubMed ID: 10421324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
